Swirl gently never shake, as agitation may degrade peptide structure
after 1 month) can ensure a response
Both peptides can help, but BPC 157 might have the upper hand when it comes to healing these types of soft tissues more directly
5-Amino-1MQ inhibits NNMT to raise NAD+ availability and prevent fat storage, administered orally once daily at 50300mg
But even today, more than three decades after BPC-157 was first synthesized, a grand total of three human studies have been conducted, and none of them were the kind of large-scale human trial thats typically part of the traditional drug-approval process
The company behind AOD-9604 knew back in 2007, after six clinical trials of 925 patients, that the drug had completely failed to treat obesity